Literature DB >> 3923526

Clonidine produces a conditioned place preference in rats.

K E Asin, D Wirtshafter.   

Abstract

The possibility that the alpha-adrenergic agonist clonidine can act as a reinforcing agent was investigated using the conditioned place preference paradigm. Using two different variants of this method we were able to demonstrate reinforcing properties of clonidine at doses of 200 and 400 micrograms/kg. These results are consistent with those obtained by other investigators using the self-administration technique, and support the view that adrenergic mechanisms may be involved in reinforcement.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3923526     DOI: 10.1007/bf00428206

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  7 in total

1.  Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents.

Authors:  N E Andén; M Grabowska; U Strömbom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

Review 2.  Catecholamine theories of reward: a critical review.

Authors:  R A Wise
Journal:  Brain Res       Date:  1978-08-25       Impact factor: 3.252

Review 3.  Drugs and reinforcement mechanisms: a critical review of the catecholamine theory.

Authors:  H C Fibiger
Journal:  Annu Rev Pharmacol Toxicol       Date:  1978       Impact factor: 13.820

4.  Catecholaminergic mechanisms of reinforcement: direct assessment by drug-self-administration.

Authors:  W M Davis; S G Smith
Journal:  Life Sci       Date:  1977-02-01       Impact factor: 5.037

5.  Reinforcing properties of clonidine in rhesus monkeys.

Authors:  W L Woolverton; W D Wessinger; R L Balster
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

6.  Possible involvement of central adrenaline neurons in vasomotor and respiratory control. Studies with clonidine and its interactions with piperoxane and yohimbine.

Authors:  P Bolme; H Corrodi; K Fuxe; T Hökfelt; P Lidbrink; M Goldstein
Journal:  Eur J Pharmacol       Date:  1974-09       Impact factor: 4.432

7.  3H-clonidine and 3H-p-aminoclonidine interactions in vitro with central and peripheral alpha 2-adrenergic receptors.

Authors:  D C U'Prichard
Journal:  Prog Clin Biol Res       Date:  1981
  7 in total
  8 in total

1.  Effects of yohimbine on the antinociceptive and place conditioning effects of opioid agonists in rodents.

Authors:  L Morales; C Perez-Garcia; L F Alguacil
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  α- and β-Adrenergic receptors differentially modulate the emission of spontaneous and amphetamine-induced 50-kHz ultrasonic vocalizations in adult rats.

Authors:  Jennifer M Wright; May R S Dobosiewicz; Paul B S Clarke
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

3.  Effect of clonidine on the responsiveness of infant rats to maternal stimuli.

Authors:  S Hansen
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Abuse liability of the dietary supplement dimethylamylamine.

Authors:  Sean B Dolan; Michael B Gatch
Journal:  Drug Alcohol Depend       Date:  2014-11-25       Impact factor: 4.492

5.  Effects of combining tactile with visual and spatial cues in conditioned place preference.

Authors:  Christopher L Cunningham; Courtney L Zerizef
Journal:  Pharmacol Biochem Behav       Date:  2014-08-01       Impact factor: 3.533

Review 6.  Treatment of heroin (diamorphine) addiction: current approaches and future prospects.

Authors:  Gerardo Gonzalez; Alison Oliveto; Thomas R Kosten
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 7.  Adrenaline rush: the role of adrenergic receptors in stimulant-induced behaviors.

Authors:  Karl T Schmidt; David Weinshenker
Journal:  Mol Pharmacol       Date:  2014-02-05       Impact factor: 4.436

8.  Role of L-type calcium channels on yohimbine-precipitated clonidine withdrawal in vivo and in vitro.

Authors:  M Barrios; I Robles; J M Baeyens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-12       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.